Tag

Biomanufacturing

Building a “Lightspeed” Culture: How a Global Pandemic Transformed Manufacturing and Distribution
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Building a “Lightspeed” Culture: How a Global Pandemic Transformed Manufacturing and Distribution

Bolstering our supply chain: Strengthening relationships with industry partners to overcome a global health crisis Making the impossible possible: “Project Lightspeed” and the development, manufacture, and distribution of the COVID-19 vaccine Where do we go from here? Ensuring this experience is a catalyst for change for our industry Key takeaways: upending our conventional ways of working and the resilience of our amazing colleagues — Mike McDermott Chief Global Supply Officer, EVP Pfizer As Chief Global Supply Officer, EVP, Mike McDermott leads all of Pfizer’s internal and external manufacturing and supply chain activities. Mike and the Pfizer Global Supply (PGS) team…

Continue reading
Delivering the Pipeline of the Future with a Commitment to Radical Simplification and Pioneering for Excellence
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Delivering the Pipeline of the Future with a Commitment to Radical Simplification and Pioneering for Excellence

Being part of the solution: Launching two medicines in record time during the pandemic Meeting growing complexity head-on Establishing communities of practitioners to re-imagine manufacturing and process development Re-thinking how we collaborate across boundaries — Susanne Hundsbaek-Pedersen Global Head Pharma of Technical Operations Roche Susanne serves as the Global Head of Pharma Technical Operations at Roche, a global biotech company. Roche delivers long-term and sustainable healthcare solutions to serve millions of patients in 150 countries. Pharma Technical Operations spans the world with sites on four continents and covers the value chain from Technical development, CMC to Commercial supplies. She is…

Continue reading
Revolutionizing The Manufacturing Landscape to Optimize Patient Outcomes
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Revolutionizing The Manufacturing Landscape to Optimize Patient Outcomes

How the pandemic has impacted innovation, technology, people and our ways of working and thinking How is Amgen transforming biomanufacturing for a faster, more data-savvy future and strengthening the balance of resiliency and efficiency Addressing unmet patient needs and establishing new markets through connected technology and other manufacturing innovations (smart materials, process automation and more) Why building integrated, collaborative, agile, high performance teams are at the heart of revolutionary manufacturing Amgen Ecovation™ – creating value through innovative and sustainable manufacturing operations — Arleen Paulino SVP Global Manufacturing Amgen Arleen Paulino, senior vice president, Manufacturing, leads Amgen’s commercial manufacturing organization where…

Continue reading
Culture of Quality Excellence Driving Competitive Advantage for Operations
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Culture of Quality Excellence Driving Competitive Advantage for Operations

Why a Culture of Quality Excellence is foundational to achieving manufacturing excellence and leads to competitive advantage for operations. Driving a culture that recognizes the Value of Quality Excellence. How to establish a Culture of Quality Excellence by focusing not only on processes and digital infrastructure but also focusing on Real-world examples of how Quality excellence is translated into manufacturing excellence, including  Vendor Management, Investigational Excellence and End to End QMS. Using Quality data in a proactive and predictive manner in order to deliver value and achieve manufacturing excellence. — RJ Doornbos VP, Global Quality Systems Bristol Myers Squibb As the Head of Global…

Continue reading
Evolving External Collaboration Models
LIFE SCIENCES, VIDEO

Evolving External Collaboration Models

Reviewing how our industry’s business partnerships have changed over time. How will this trend continue into the future? Dividing the work and sharing the burden: How should biopharmaceutical companies align their objectives of cost management, risk management, productivity, and growth? Maturing business relationships over time through common culture through two-way communication, collaboration, and cooperation Walking through examples of external collaboration: What works, what does not, and why? — Joanne Beck EVP, Global Pharmaceutical Development & Operations Celgene Corporation Dr. Joanne Beck is EVP Global Pharmaceutical Development and Operations at Celgene where she oversees the company’s Pharmaceutical Development, Global Manufacturing Operations,…

Continue reading
Accelerating Delivery of New Medicines
LIFE SCIENCES, VIDEO

Accelerating Delivery of New Medicines

Examining technologies, tools, and platforms to accelerate the pace of biopharmaceutical development How development velocity can affect clinical development and what we learn in this process Examining how acceleration impacts our quality, regulatory, and supply chain functions. How do we all keep pace? Understanding how acceleration affects data monitoring and analytics throughout the product lifecycle Discussing what steps we as an industry will need to take together to make this the new normal — Jerry Cacia SVP, Head Global Technical Development Genentech Jerry is responsible for Roche’s Global Technical Development organization. This scope includes responsibility for developing manufacturing processes and…

Continue reading
Boosting Traceability and Security in the Supply Chain with Serialization
LIFE SCIENCES, VIDEO

Boosting Traceability and Security in the Supply Chain with Serialization

What is serialization? Global serialization mandates Impact on manufacturing and the pharma supply chain Implementation challenges Technologies – Now and into the future — George Skillin Sr. Director – Global Engineering Pfizer George Skillin is the Senior Director of Pfizer Global Engineering, where he manages a team of 35 engineering professionals in the Process, Equipment, Automation Engineering disciplines and manages the Global Serialization and Industrial Control System Cyber Security Programs for Pfizer. George joined Pfizer in 2002 taking on a 2+ year international assignment as a member of the Site Leadership Team in conjunction with the design, construction, and start-up…

Continue reading
Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?
LIFE SCIENCES, VIDEO

Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?

Debating the merits of nimble and flexible facilities versus manufacturing battleships Preparing your pilot plants and manufacturing facilities to move forward with Phase II-III approvals Forecasting requirements for optimizing manufacturing equipment, facilities and partners to increase speed to market Achieving business goals to better manage times of product and economic uncertainty Putting theory into practice: Implementing key metrics to improve manufacturing flexibility — Uwe Buecheler Corporate SVP, Biopharmaceuticals Boehringer Ingelheim Uwe Buecheler, joint Boehringer Ingelheim (formerly Dr. Karl Thomae GmbH) in 1991. During his time at Boehringer Ingelheim he held different positions in Biopharmaceuticals in Regulatory Affairs, Biological Safety and…

Continue reading
Panel: The Global Talent War in Biomanufacturing
LIFE SCIENCES, VIDEO

Panel: The Global Talent War in Biomanufacturing

Learning about global talent trends influencing the job market for senior executives and those with critical, specialized skill sets Creating effective attraction, retention and development plans for top talent Navigating the generational talent gap in critical functions Understanding which leadership differentiators are needed to make it to Senior Executive and C-Level roles — Sanat Chattopadhyay EVP & President, Merck Manufacturing Division Merck Sanat Chattopadhyay is responsible for Merck’s worldwide manufacturing and supply operations supporting annual global sales revenues exceeding $40 billion. Merck is known as MSD outside of the U.S. and Canada. Sanat oversees a network of 50 pharmaceuticals, vaccines,…

Continue reading
Ready or Not, Digitization Will Transform Biomanufacturing
LIFE SCIENCES, VIDEO

Ready or Not, Digitization Will Transform Biomanufacturing

The Amazon-ization of Retail – How an industry-wide disruption unfolds The ongoing digitization of the Biopharma ecosystem – The transformation of drug delivery The Possible? Likely? Inevitable? Impacts on Tech Ops – Recent new roles analysis What it all means for Biomanufacturing leadership — Pascal Bécotte Global Leader – Operations & Supply Chain Practice Russell Reynolds Pascal leads the firm’s global Operations & Supply Chain Officers Practice and is a key member of the Healthcare and Industrial teams. He advises global clients on their overall talent strategy, particularly with respect to leadership assessment and succession planning. With more than 16…

Continue reading
Digital Transformation with Business Impact for Manufacturers
LIFE SCIENCES, VIDEO

Digital Transformation with Business Impact for Manufacturers

Chris Dobbrow, the Senior Vice President of Sight Machine, spoke at the Biomanufacturing World Summit in San Diego, CA in November 2016. His presentation was entitled: Digital Transformation with Business Impact for Manufacturers Proving that the most valuable data in manufacturing is from production itself Choosing the right goals and outcomes to make a difference Connecting disparate IT systems together into a unified whole Building a scalable approach for the enterprise, step-by-step: Start small to go big Understanding why data lakes and bespoke projects don’t scale Illustrating successful projects with concrete examples

Continue reading
A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build
LIFE SCIENCES, VIDEO

A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build

David Radspinner  spoke  on November 14th at the 2016 edition of the Biomanufacturing World Summit. His session was entitled, A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build. In March 2016, David Radspinner was appointed as the General Manager for the GEHC LS newly created BioPark business. Previously, in January of 2014, GE acquired the HyClone Cell Culture business and subsequently David was appointed as its Hold Separate Manager. David earned a PhD in Analytical Chemistry from the University of Arizona and has spent over 14 years working within the areas of…

Continue reading